Global Viral Vector and Plasmid DNA Market Insights and Forecast to 2028

Report ID: 1240708 | Published Date: Jan 2025 | No. of Page: 126 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Plasmid DNA
        1.2.3 Viral Vector
    1.3 Market by Application
        1.3.1 Global Viral Vector and Plasmid DNA Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Virus Infection
        1.3.4 Hereditary Disease
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Viral Vector and Plasmid DNA Market Perspective (2017-2028)
    2.2 Viral Vector and Plasmid DNA Growth Trends by Region
        2.2.1 Viral Vector and Plasmid DNA Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Viral Vector and Plasmid DNA Historic Market Size by Region (2017-2022)
        2.2.3 Viral Vector and Plasmid DNA Forecasted Market Size by Region (2023-2028)
    2.3 Viral Vector and Plasmid DNA Market Dynamics
        2.3.1 Viral Vector and Plasmid DNA Industry Trends
        2.3.2 Viral Vector and Plasmid DNA Market Drivers
        2.3.3 Viral Vector and Plasmid DNA Market Challenges
        2.3.4 Viral Vector and Plasmid DNA Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Viral Vector and Plasmid DNA Players by Revenue
        3.1.1 Global Top Viral Vector and Plasmid DNA Players by Revenue (2017-2022)
        3.1.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Players (2017-2022)
    3.2 Global Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Viral Vector and Plasmid DNA Revenue
    3.4 Global Viral Vector and Plasmid DNA Market Concentration Ratio
        3.4.1 Global Viral Vector and Plasmid DNA Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Viral Vector and Plasmid DNA Revenue in 2021
    3.5 Viral Vector and Plasmid DNA Key Players Head office and Area Served
    3.6 Key Players Viral Vector and Plasmid DNA Product Solution and Service
    3.7 Date of Enter into Viral Vector and Plasmid DNA Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector and Plasmid DNA Breakdown Data by Type
    4.1 Global Viral Vector and Plasmid DNA Historic Market Size by Type (2017-2022)
    4.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2023-2028)
5 Viral Vector and Plasmid DNA Breakdown Data by Application
    5.1 Global Viral Vector and Plasmid DNA Historic Market Size by Application (2017-2022)
    5.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Viral Vector and Plasmid DNA Market Size (2017-2028)
    6.2 North America Viral Vector and Plasmid DNA Market Size by Type
        6.2.1 North America Viral Vector and Plasmid DNA Market Size by Type (2017-2022)
        6.2.2 North America Viral Vector and Plasmid DNA Market Size by Type (2023-2028)
        6.2.3 North America Viral Vector and Plasmid DNA Market Share by Type (2017-2028)
    6.3 North America Viral Vector and Plasmid DNA Market Size by Application
        6.3.1 North America Viral Vector and Plasmid DNA Market Size by Application (2017-2022)
        6.3.2 North America Viral Vector and Plasmid DNA Market Size by Application (2023-2028)
        6.3.3 North America Viral Vector and Plasmid DNA Market Share by Application (2017-2028)
    6.4 North America Viral Vector and Plasmid DNA Market Size by Country
        6.4.1 North America Viral Vector and Plasmid DNA Market Size by Country (2017-2022)
        6.4.2 North America Viral Vector and Plasmid DNA Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Viral Vector and Plasmid DNA Market Size (2017-2028)
    7.2 Europe Viral Vector and Plasmid DNA Market Size by Type
        7.2.1 Europe Viral Vector and Plasmid DNA Market Size by Type (2017-2022)
        7.2.2 Europe Viral Vector and Plasmid DNA Market Size by Type (2023-2028)
        7.2.3 Europe Viral Vector and Plasmid DNA Market Share by Type (2017-2028)
    7.3 Europe Viral Vector and Plasmid DNA Market Size by Application
        7.3.1 Europe Viral Vector and Plasmid DNA Market Size by Application (2017-2022)
        7.3.2 Europe Viral Vector and Plasmid DNA Market Size by Application (2023-2028)
        7.3.3 Europe Viral Vector and Plasmid DNA Market Share by Application (2017-2028)
    7.4 Europe Viral Vector and Plasmid DNA Market Size by Country
        7.4.1 Europe Viral Vector and Plasmid DNA Market Size by Country (2017-2022)
        7.4.2 Europe Viral Vector and Plasmid DNA Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size (2017-2028)
    8.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type
        8.2.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Viral Vector and Plasmid DNA Market Share by Type (2017-2028)
    8.3 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application
        8.3.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Viral Vector and Plasmid DNA Market Share by Application (2017-2028)
    8.4 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region
        8.4.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Viral Vector and Plasmid DNA Market Size (2017-2028)
    9.2 Latin America Viral Vector and Plasmid DNA Market Size by Type
        9.2.1 Latin America Viral Vector and Plasmid DNA Market Size by Type (2017-2022)
        9.2.2 Latin America Viral Vector and Plasmid DNA Market Size by Type (2023-2028)
        9.2.3 Latin America Viral Vector and Plasmid DNA Market Share by Type (2017-2028)
    9.3 Latin America Viral Vector and Plasmid DNA Market Size by Application
        9.3.1 Latin America Viral Vector and Plasmid DNA Market Size by Application (2017-2022)
        9.3.2 Latin America Viral Vector and Plasmid DNA Market Size by Application (2023-2028)
        9.3.3 Latin America Viral Vector and Plasmid DNA Market Share by Application (2017-2028)
    9.4 Latin America Viral Vector and Plasmid DNA Market Size by Country
        9.4.1 Latin America Viral Vector and Plasmid DNA Market Size by Country (2017-2022)
        9.4.2 Latin America Viral Vector and Plasmid DNA Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size (2017-2028)
    10.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type
        10.2.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Viral Vector and Plasmid DNA Market Share by Type (2017-2028)
    10.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application
        10.3.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Viral Vector and Plasmid DNA Market Share by Application (2017-2028)
    10.4 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country
        10.4.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Brammer Bio
        11.1.1 Brammer Bio Company Details
        11.1.2 Brammer Bio Business Overview
        11.1.3 Brammer Bio Viral Vector and Plasmid DNA Introduction
        11.1.4 Brammer Bio Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.1.5 Brammer Bio Recent Developments
    11.2 Oxford BioMedica
        11.2.1 Oxford BioMedica Company Details
        11.2.2 Oxford BioMedica Business Overview
        11.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Introduction
        11.2.4 Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.2.5 Oxford BioMedica Recent Developments
    11.3 Cobra Biologics
        11.3.1 Cobra Biologics Company Details
        11.3.2 Cobra Biologics Business Overview
        11.3.3 Cobra Biologics Viral Vector and Plasmid DNA Introduction
        11.3.4 Cobra Biologics Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.3.5 Cobra Biologics Recent Developments
    11.4 FinVector
        11.4.1 FinVector Company Details
        11.4.2 FinVector Business Overview
        11.4.3 FinVector Viral Vector and Plasmid DNA Introduction
        11.4.4 FinVector Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.4.5 FinVector Recent Developments
    11.5 Lonza
        11.5.1 Lonza Company Details
        11.5.2 Lonza Business Overview
        11.5.3 Lonza Viral Vector and Plasmid DNA Introduction
        11.5.4 Lonza Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.5.5 Lonza Recent Developments
    11.6 BioReliance
        11.6.1 BioReliance Company Details
        11.6.2 BioReliance Business Overview
        11.6.3 BioReliance Viral Vector and Plasmid DNA Introduction
        11.6.4 BioReliance Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.6.5 BioReliance Recent Developments
    11.7 MolMed
        11.7.1 MolMed Company Details
        11.7.2 MolMed Business Overview
        11.7.3 MolMed Viral Vector and Plasmid DNA Introduction
        11.7.4 MolMed Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.7.5 MolMed Recent Developments
    11.8 FUJIFILM Diosynth Biotechnologies
        11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
        11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
        11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Introduction
        11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
    11.9 UniQure
        11.9.1 UniQure Company Details
        11.9.2 UniQure Business Overview
        11.9.3 UniQure Viral Vector and Plasmid DNA Introduction
        11.9.4 UniQure Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.9.5 UniQure Recent Developments
    11.10 Aldevron
        11.10.1 Aldevron Company Details
        11.10.2 Aldevron Business Overview
        11.10.3 Aldevron Viral Vector and Plasmid DNA Introduction
        11.10.4 Aldevron Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.10.5 Aldevron Recent Developments
    11.11 Richter-Helm
        11.11.1 Richter-Helm Company Details
        11.11.2 Richter-Helm Business Overview
        11.11.3 Richter-Helm Viral Vector and Plasmid DNA Introduction
        11.11.4 Richter-Helm Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.11.5 Richter-Helm Recent Developments
    11.12 Eurogentec
        11.12.1 Eurogentec Company Details
        11.12.2 Eurogentec Business Overview
        11.12.3 Eurogentec Viral Vector and Plasmid DNA Introduction
        11.12.4 Eurogentec Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.12.5 Eurogentec Recent Developments
    11.13 OBiO Technology
        11.13.1 OBiO Technology Company Details
        11.13.2 OBiO Technology Business Overview
        11.13.3 OBiO Technology Viral Vector and Plasmid DNA Introduction
        11.13.4 OBiO Technology Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.13.5 OBiO Technology Recent Developments
    11.14 Yposkesi
        11.14.1 Yposkesi Company Details
        11.14.2 Yposkesi Business Overview
        11.14.3 Yposkesi Viral Vector and Plasmid DNA Introduction
        11.14.4 Yposkesi Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.14.5 Yposkesi Recent Developments
    11.15 Cell and Gene Therapy Catapult
        11.15.1 Cell and Gene Therapy Catapult Company Details
        11.15.2 Cell and Gene Therapy Catapult Business Overview
        11.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Introduction
        11.15.4 Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.15.5 Cell and Gene Therapy Catapult Recent Developments
    11.16 MassBiologics
        11.16.1 MassBiologics Company Details
        11.16.2 MassBiologics Business Overview
        11.16.3 MassBiologics Viral Vector and Plasmid DNA Introduction
        11.16.4 MassBiologics Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.16.5 MassBiologics Recent Developments
    11.17 Biovian
        11.17.1 Biovian Company Details
        11.17.2 Biovian Business Overview
        11.17.3 Biovian Viral Vector and Plasmid DNA Introduction
        11.17.4 Biovian Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.17.5 Biovian Recent Developments
    11.18 VGXI
        11.18.1 VGXI Company Details
        11.18.2 VGXI Business Overview
        11.18.3 VGXI Viral Vector and Plasmid DNA Introduction
        11.18.4 VGXI Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.18.5 VGXI Recent Developments
    11.19 Gene Synthesis
        11.19.1 Gene Synthesis Company Details
        11.19.2 Gene Synthesis Business Overview
        11.19.3 Gene Synthesis Viral Vector and Plasmid DNA Introduction
        11.19.4 Gene Synthesis Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.19.5 Gene Synthesis Recent Developments
    11.20 PlasmidFactory
        11.20.1 PlasmidFactory Company Details
        11.20.2 PlasmidFactory Business Overview
        11.20.3 PlasmidFactory Viral Vector and Plasmid DNA Introduction
        11.20.4 PlasmidFactory Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.20.5 PlasmidFactory Recent Developments
    11.21 Jikai Gene
        11.21.1 Jikai Gene Company Details
        11.21.2 Jikai Gene Business Overview
        11.21.3 Jikai Gene Viral Vector and Plasmid DNA Introduction
        11.21.4 Jikai Gene Revenue in Viral Vector and Plasmid DNA Business (2017-2022)
        11.21.5 Jikai Gene Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Plasmid DNA
    Table 3. Key Players of Viral Vector
    Table 4. Global Viral Vector and Plasmid DNA Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Viral Vector and Plasmid DNA Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Viral Vector and Plasmid DNA Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Viral Vector and Plasmid DNA Market Share by Region (2017-2022)
    Table 8. Global Viral Vector and Plasmid DNA Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Viral Vector and Plasmid DNA Market Share by Region (2023-2028)
    Table 10. Viral Vector and Plasmid DNA Market Trends
    Table 11. Viral Vector and Plasmid DNA Market Drivers
    Table 12. Viral Vector and Plasmid DNA Market Challenges
    Table 13. Viral Vector and Plasmid DNA Market Restraints
    Table 14. Global Viral Vector and Plasmid DNA Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Viral Vector and Plasmid DNA Revenue Share by Players (2017-2022)
    Table 16. Global Top Viral Vector and Plasmid DNA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2021)
    Table 17. Ranking of Global Top Viral Vector and Plasmid DNA Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Viral Vector and Plasmid DNA Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Viral Vector and Plasmid DNA Product Solution and Service
    Table 21. Date of Enter into Viral Vector and Plasmid DNA Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Viral Vector and Plasmid DNA Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2017-2022)
    Table 25. Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2023-2028)
    Table 27. Global Viral Vector and Plasmid DNA Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Viral Vector and Plasmid DNA Revenue Share by Application (2017-2022)
    Table 29. Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Viral Vector and Plasmid DNA Revenue Share by Application (2023-2028)
    Table 31. North America Viral Vector and Plasmid DNA Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Viral Vector and Plasmid DNA Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Viral Vector and Plasmid DNA Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Viral Vector and Plasmid DNA Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Viral Vector and Plasmid DNA Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Viral Vector and Plasmid DNA Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Viral Vector and Plasmid DNA Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Viral Vector and Plasmid DNA Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Viral Vector and Plasmid DNA Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Viral Vector and Plasmid DNA Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Viral Vector and Plasmid DNA Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Viral Vector and Plasmid DNA Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Viral Vector and Plasmid DNA Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Viral Vector and Plasmid DNA Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Viral Vector and Plasmid DNA Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Viral Vector and Plasmid DNA Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Viral Vector and Plasmid DNA Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Viral Vector and Plasmid DNA Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Viral Vector and Plasmid DNA Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Viral Vector and Plasmid DNA Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Viral Vector and Plasmid DNA Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Viral Vector and Plasmid DNA Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Viral Vector and Plasmid DNA Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Viral Vector and Plasmid DNA Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Viral Vector and Plasmid DNA Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Viral Vector and Plasmid DNA Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Viral Vector and Plasmid DNA Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Viral Vector and Plasmid DNA Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Viral Vector and Plasmid DNA Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Viral Vector and Plasmid DNA Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Brammer Bio Company Details
    Table 62. Brammer Bio Business Overview
    Table 63. Brammer Bio Viral Vector and Plasmid DNA Product
    Table 64. Brammer Bio Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 65. Brammer Bio Recent Developments
    Table 66. Oxford BioMedica Company Details
    Table 67. Oxford BioMedica Business Overview
    Table 68. Oxford BioMedica Viral Vector and Plasmid DNA Product
    Table 69. Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 70. Oxford BioMedica Recent Developments
    Table 71. Cobra Biologics Company Details
    Table 72. Cobra Biologics Business Overview
    Table 73. Cobra Biologics Viral Vector and Plasmid DNA Product
    Table 74. Cobra Biologics Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 75. Cobra Biologics Recent Developments
    Table 76. FinVector Company Details
    Table 77. FinVector Business Overview
    Table 78. FinVector Viral Vector and Plasmid DNA Product
    Table 79. FinVector Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 80. FinVector Recent Developments
    Table 81. Lonza Company Details
    Table 82. Lonza Business Overview
    Table 83. Lonza Viral Vector and Plasmid DNA Product
    Table 84. Lonza Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 85. Lonza Recent Developments
    Table 86. BioReliance Company Details
    Table 87. BioReliance Business Overview
    Table 88. BioReliance Viral Vector and Plasmid DNA Product
    Table 89. BioReliance Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 90. BioReliance Recent Developments
    Table 91. MolMed Company Details
    Table 92. MolMed Business Overview
    Table 93. MolMed Viral Vector and Plasmid DNA Product
    Table 94. MolMed Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 95. MolMed Recent Developments
    Table 96. FUJIFILM Diosynth Biotechnologies Company Details
    Table 97. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 98. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product
    Table 99. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 100. FUJIFILM Diosynth Biotechnologies Recent Developments
    Table 101. UniQure Company Details
    Table 102. UniQure Business Overview
    Table 103. UniQure Viral Vector and Plasmid DNA Product
    Table 104. UniQure Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 105. UniQure Recent Developments
    Table 106. Aldevron Company Details
    Table 107. Aldevron Business Overview
    Table 108. Aldevron Viral Vector and Plasmid DNA Product
    Table 109. Aldevron Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 110. Aldevron Recent Developments
    Table 111. Richter-Helm Company Details
    Table 112. Richter-Helm Business Overview
    Table 113. Richter-Helm Viral Vector and Plasmid DNA Product
    Table 114. Richter-Helm Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 115. Richter-Helm Recent Developments
    Table 116. Eurogentec Company Details
    Table 117. Eurogentec Business Overview
    Table 118. Eurogentec Viral Vector and Plasmid DNA Product
    Table 119. Eurogentec Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 120. Eurogentec Recent Developments
    Table 121. OBiO Technology Company Details
    Table 122. OBiO Technology Business Overview
    Table 123. OBiO Technology Viral Vector and Plasmid DNA Product
    Table 124. OBiO Technology Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 125. OBiO Technology Recent Developments
    Table 126. Yposkesi Company Details
    Table 127. Yposkesi Business Overview
    Table 128. Yposkesi Viral Vector and Plasmid DNA Product
    Table 129. Yposkesi Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 130. Yposkesi Recent Developments
    Table 131. Cell and Gene Therapy Catapult Company Details
    Table 132. Cell and Gene Therapy Catapult Business Overview
    Table 133. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product
    Table 134. Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 135. Cell and Gene Therapy Catapult Recent Developments
    Table 136. MassBiologics Company Details
    Table 137. MassBiologics Business Overview
    Table 138. MassBiologics Viral Vector and Plasmid DNA Product
    Table 139. MassBiologics Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 140. MassBiologics Recent Developments
    Table 141. Biovian Company Details
    Table 142. Biovian Business Overview
    Table 143. Biovian Viral Vector and Plasmid DNA Product
    Table 144. Biovian Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 145. Biovian Recent Developments
    Table 146. VGXI Company Details
    Table 147. VGXI Business Overview
    Table 148. VGXI Viral Vector and Plasmid DNA Product
    Table 149. VGXI Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 150. VGXI Recent Developments
    Table 151. Gene Synthesis Company Details
    Table 152. Gene Synthesis Business Overview
    Table 153. Gene Synthesis Viral Vector and Plasmid DNA Product
    Table 154. Gene Synthesis Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 155. Gene Synthesis Recent Developments
    Table 156. PlasmidFactory Company Details
    Table 157. PlasmidFactory Business Overview
    Table 158. PlasmidFactory Viral Vector and Plasmid DNA Product
    Table 159. PlasmidFactory Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 160. PlasmidFactory Recent Developments
    Table 161. Jikai Gene Company Details
    Table 162. Jikai Gene Business Overview
    Table 163. Jikai Gene Viral Vector and Plasmid DNA Product
    Table 164. Jikai Gene Revenue in Viral Vector and Plasmid DNA Business (2017-2022) & (US$ Million)
    Table 165. Jikai Gene Recent Developments
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vector and Plasmid DNA Market Share by Type: 2021 VS 2028
    Figure 2. Plasmid DNA Features
    Figure 3. Viral Vector Features
    Figure 4. Global Viral Vector and Plasmid DNA Market Share by Application: 2021 VS 2028
    Figure 5. Cancer Case Studies
    Figure 6. Virus Infection Case Studies
    Figure 7. Hereditary Disease Case Studies
    Figure 8. Viral Vector and Plasmid DNA Report Years Considered
    Figure 9. Global Viral Vector and Plasmid DNA Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Viral Vector and Plasmid DNA Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Viral Vector and Plasmid DNA Market Share by Region: 2021 VS 2028
    Figure 12. Global Viral Vector and Plasmid DNA Market Share by Players in 2021
    Figure 13. Global Top Viral Vector and Plasmid DNA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Viral Vector and Plasmid DNA Revenue in 2021
    Figure 15. North America Viral Vector and Plasmid DNA Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Viral Vector and Plasmid DNA Market Size Market Share by Type (2017-2028)
    Figure 17. North America Viral Vector and Plasmid DNA Market Size Market Share by Application (2017-2028)
    Figure 18. North America Viral Vector and Plasmid DNA Market Size Share by Country (2017-2028)
    Figure 19. United States Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Viral Vector and Plasmid DNA Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Viral Vector and Plasmid DNA Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Viral Vector and Plasmid DNA Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Viral Vector and Plasmid DNA Market Size Share by Country (2017-2028)
    Figure 25. Germany Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Viral Vector and Plasmid DNA Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Viral Vector and Plasmid DNA Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Viral Vector and Plasmid DNA Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Viral Vector and Plasmid DNA Market Size Share by Region (2017-2028)
    Figure 35. China Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Viral Vector and Plasmid DNA Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Viral Vector and Plasmid DNA Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Viral Vector and Plasmid DNA Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Viral Vector and Plasmid DNA Market Size Share by Country (2017-2028)
    Figure 45. Mexico Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Viral Vector and Plasmid DNA Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Viral Vector and Plasmid DNA Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Viral Vector and Plasmid DNA Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Viral Vector and Plasmid DNA Market Size Share by Country (2017-2028)
    Figure 51. Turkey Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Viral Vector and Plasmid DNA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Brammer Bio Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 55. Oxford BioMedica Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 56. Cobra Biologics Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 57. FinVector Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 58. Lonza Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 59. BioReliance Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 60. MolMed Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 61. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 62. UniQure Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 63. Aldevron Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 64. Richter-Helm Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 65. Eurogentec Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 66. OBiO Technology Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 67. Yposkesi Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 68. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 69. MassBiologics Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 70. Biovian Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 71. VGXI Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 72. Gene Synthesis Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 73. PlasmidFactory Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 74. Jikai Gene Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
MolMed
FUJIFILM Diosynth Biotechnologies
UniQure
Aldevron
Richter-Helm
Eurogentec
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
PlasmidFactory
Jikai Gene
Frequently Asked Questions
Viral Vector and Plasmid DNA report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Viral Vector and Plasmid DNA report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Viral Vector and Plasmid DNA report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports